Invention Grant
- Patent Title: Neutralizing anti-influenza A virus antibodies and uses thereof
- Patent Title (中): 中和抗甲型流感病毒抗体及其用途
-
Application No.: US14233719Application Date: 2011-07-18
-
Publication No.: US09587010B2Publication Date: 2017-03-07
- Inventor: Antonio Lanzavecchia
- Applicant: Antonio Lanzavecchia
- Applicant Address: CH Bellinzona
- Assignee: THE INSTITUTE FOR RESEARCH IN BIOMEDICINE
- Current Assignee: THE INSTITUTE FOR RESEARCH IN BIOMEDICINE
- Current Assignee Address: CH Bellinzona
- Agency: Glance Law Group
- Agent Melissa Pytel
- International Application: PCT/IB2011/002329 WO 20110718
- International Announcement: WO2013/011347 WO 20130124
- Main IPC: C07K16/10
- IPC: C07K16/10 ; G01N33/569 ; C07K14/005

Abstract:
The invention relates to antibodies, and antigen binding fragments thereof, that specifically bind to an epitope in the stem region of an influenza A hemagglutinin trimer and neutralize a group 1 subtype and a group 2 subtype of influenza A virus. The invention also relates to nucleic acids that encode, immortalized B cells and cultured single plasma cells that produce, and to epitopes that bind to such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies, antibody fragments, and epitopes in screening methods as well as in the diagnosis, treatment and prevention of influenza A virus infection.
Public/Granted literature
- US20140271655A1 NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF Public/Granted day:2014-09-18
Information query